Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2021 | 1 |
2022 | 2 |
2023 | 3 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
PLoS One. 2022 Oct 18;17(10):e0274943. doi: 10.1371/journal.pone.0274943. eCollection 2022.
PLoS One. 2022.
PMID: 36256646
Free PMC article.
Clinical Trial.
A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults.
Vanni T, da Graça Salomão M, Viscondi JYK, Braga PE, da Silva A, de Oliveira Piorelli R, do Prado Santos J, Gattás VL, Lucchesi MBB, de Oliveira MMM, Koike ME, Campos LMA, Coelho EB, Weckx LY, Lara AN, Paiva TM, Timenetsky MDCST, Precioso AR.
Vanni T, et al.
Vaccine. 2023 May 22;41(22):3454-3460. doi: 10.1016/j.vaccine.2023.04.050. Epub 2023 Apr 28.
Vaccine. 2023.
PMID: 37121800
Clinical Trial.
Item in Clipboard
GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
Pinhata JMW, Brandao AP, Gallo JF, Oliveira RS, Ferrazoli L.
Pinhata JMW, et al.
Diagn Microbiol Infect Dis. 2023 Feb;105(2):115856. doi: 10.1016/j.diagmicrobio.2022.115856. Epub 2022 Nov 7.
Diagn Microbiol Infect Dis. 2023.
PMID: 36446302
Item in Clipboard
A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
Pinhata JMW, Ferrazoli L, Mendes FF, Gonçalves MG, Rabello MCDS, Ghisi KT, Simonsen V, Cavalin RF, Lindoso AABP, de Oliveira RS.
Pinhata JMW, et al.
Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):73-85. doi: 10.1007/s10096-023-04693-8. Epub 2023 Nov 9.
Eur J Clin Microbiol Infect Dis. 2024.
PMID: 37943394
Item in Clipboard
Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
Pinhata JMW, Brandao AP, Mendes FF, Rabello MCDS, Ferrazoli L, de Oliveira RS.
Pinhata JMW, et al.
Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2551-2561. doi: 10.1007/s10096-021-04316-0. Epub 2021 Jul 23.
Eur J Clin Microbiol Infect Dis. 2021.
PMID: 34297229
Item in Clipboard
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
Mesquita JT, Tempone AG, Reimão JQ.
Mesquita JT, et al.
Acta Trop. 2014 Feb;130:112-6. doi: 10.1016/j.actatropica.2013.11.003. Epub 2013 Nov 13.
Acta Trop. 2014.
PMID: 24239532
Item in Clipboard
Cite
Cite